If budget is a concern, the $200 monthly price point buys you ingredients you could source individually for far less
The approval for Chronic Inflammatory Demyelinating Polyneuropathy (CDIP), announced Monday, was backed by data from the ADVANCE-CIDP 2 clinical trial, where treatment with GAMMAGARD LIQUID yielded a 94.4% responder rate, indicating a significant improvement in functional disability
doi:10.1007/s13300-024-01659-7 63
The research findings stimulated the study of GIT in this population and several alterations were identified, such as: Low activity of digestive enzymes responsible for hydrolyzing carbohydrates and proteins, gastroesophageal reflux, food allergy and dysfunction of secretin production [79,81,82]
If approved, you can get Wegovy for $0 from any participating retail pharmacy by showing the Wegovy Savings Card from Novo Nordisk